These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11375228)

  • 1. Oral mucolytic drugs for exacerbations of chronic obstructive pulmonary disease: systematic review.
    Poole PJ; Black PN
    BMJ; 2001 May; 322(7297):1271-4. PubMed ID: 11375228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Chong J; Cates CJ
    Cochrane Database Syst Rev; 2015 Jul; (7):CD001287. PubMed ID: 26222376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN; Cates CJ
    Cochrane Database Syst Rev; 2012 Aug; (8):CD001287. PubMed ID: 22895919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001287. PubMed ID: 16855965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Black PN
    Cochrane Database Syst Rev; 2010 Feb; (2):CD001287. PubMed ID: 20166060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2003; (2):CD001287. PubMed ID: 12804402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole PJ; Black PN
    Cochrane Database Syst Rev; 2000; (2):CD001287. PubMed ID: 10796634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010010. PubMed ID: 28626902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease.
    Teo E; House H; Lockhart K; Purchuri SN; Pushparajah J; Cripps AW; van Driel ML
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010010. PubMed ID: 25201571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A; Poole P
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
    Poole PJ; Black PN
    Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evidence for the use of oral mucolytic agents in chronic obstructive pulmonary disease (COPD).
    Davies L; Calverley PM
    Br Med Bull; 2010; 93():217-27. PubMed ID: 20031934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
    Allegra L; Cordaro CI; Grassi C
    Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of mucolytics in the management of COPD.
    Poole PJ
    Int J Chron Obstruct Pulmon Dis; 2006; 1(2):123-8. PubMed ID: 18046889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M; Rogliani P; Calzetta L; Hanania NA; Matera MG
    COPD; 2017 Oct; 14(5):552-563. PubMed ID: 28753070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.
    Janjua S; Mathioudakis AG; Fortescue R; Walker RA; Sharif S; Threapleton CJ; Dias S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013198. PubMed ID: 33448349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute exacerbations of chronic bronchitis: focusing management for optimum results.
    Aboussouan LS
    Postgrad Med; 1996 Apr; 99(4):89-90, 95-8, 101-2. PubMed ID: 8604417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.
    Arandjus C; Black PN; Poole PJ; Wood Baker R; Steurer-Stey C
    Respir Med; 2006 Oct; 100(10):1671-81. PubMed ID: 16934969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.